Van der Linden, M.; Van Gaever, B.; Raman, L.; Vermaelen, K.; Demedts, I.; Surmont, V.; Himpe, U.; Lievens, Y.; Ferdinande, L.; Dedeurwaerdere, F.;
et al. Application of an Ultrasensitive NGS-Based Blood Test for the Diagnosis of Early-Stage Lung Cancer: Sensitivity, a Hurdle Still Difficult to Overcome. Cancers 2022, 14, 2031.
https://doi.org/10.3390/cancers14082031
AMA Style
Van der Linden M, Van Gaever B, Raman L, Vermaelen K, Demedts I, Surmont V, Himpe U, Lievens Y, Ferdinande L, Dedeurwaerdere F,
et al. Application of an Ultrasensitive NGS-Based Blood Test for the Diagnosis of Early-Stage Lung Cancer: Sensitivity, a Hurdle Still Difficult to Overcome. Cancers. 2022; 14(8):2031.
https://doi.org/10.3390/cancers14082031
Chicago/Turabian Style
Van der Linden, Malaïka, Bram Van Gaever, Lennart Raman, Karim Vermaelen, Ingel Demedts, Veerle Surmont, Ulrike Himpe, Yolande Lievens, Liesbeth Ferdinande, Franceska Dedeurwaerdere,
and et al. 2022. "Application of an Ultrasensitive NGS-Based Blood Test for the Diagnosis of Early-Stage Lung Cancer: Sensitivity, a Hurdle Still Difficult to Overcome" Cancers 14, no. 8: 2031.
https://doi.org/10.3390/cancers14082031
APA Style
Van der Linden, M., Van Gaever, B., Raman, L., Vermaelen, K., Demedts, I., Surmont, V., Himpe, U., Lievens, Y., Ferdinande, L., Dedeurwaerdere, F., Van der Meulen, J., Claes, K., Menten, B., & Van Dorpe, J.
(2022). Application of an Ultrasensitive NGS-Based Blood Test for the Diagnosis of Early-Stage Lung Cancer: Sensitivity, a Hurdle Still Difficult to Overcome. Cancers, 14(8), 2031.
https://doi.org/10.3390/cancers14082031
